Phthalimide‐tethered imidazolium salts: Synthesis, characterization, enzyme inhibitory properties, and in silico studies
作者:Murat Yiğit、Yeliz Demir、Duygu Barut Celepci、Tuğba Taskin‐Tok、Ali Arınç、Beyhan Yiğit、Muhittin Aygün、İsmail Özdemir、İlhami Gülçin
DOI:10.1002/ardp.202200348
日期:2022.12
imidazolium salts were prepared in good yield by the reaction between 1-alkylimidazole and a variety of alkyl halides. The structures of the compounds were identified by FT-IR, 1H NMR, and 13C NMR spectroscopy, elemental analysis, and mass spectrometry. The crystal structure of 1b was determined by the single-crystal X-ray diffraction method. The phthalimide-tethered imidazolium salts exhibited inhibition
通过1-烷基咪唑与多种烷基卤化物的反应,以良好的收率制备了一系列新的咪唑鎓盐。通过红外光谱、1 H NMR、13 C NMR光谱、元素分析和质谱鉴定了化合物的结构。1b的晶体结构通过单晶X射线衍射法确定。邻苯二甲酰亚胺系咪唑盐对乙酰胆碱酯酶 (AChE) 和人碳酸酐酶 (hCAs) I 和 II 具有抑制能力,其中K iAChE 的值范围为 24.63 ± 3.45 至 305.51 ± 35.98 nM,hCA I 的值为 33.56 ± 3.71 至 218.01 ± 25.21 nM,hCA II 的值为 17.75 ± 0.96 至 308.67 ± 13.73 nM。结果表明,新型咪唑盐在阿尔茨海默病、癫痫、青光眼和白血病的治疗中发挥关键作用,这与其对hCA I、hCA II和AChE的抑制能力有关。分子对接和计算机吸收、分布、代谢、排泄和毒性研究用于研究咪唑盐如何与特定蛋白质靶